PFE - RedHill secures funding for Phase 2 study of COVID-19 treatment December, 04 2023 09:35 AM Pfizer Inc. 2023-12-04 09:35:58 ET More on RedHill RedHill stock nearly doubles in value pre-market on a five-year FDA exclusivity grant Financial information for RedHill For further details see: RedHill secures funding for Phase 2 study of COVID-19 treatment